Kane Biotech (KNE) Insider Trading & Ownership C$0.04 0.00 (0.00%) As of 05/20/2026 12:16 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartHeadlinesInsider TradesBuy This Stock Kane Biotech (CVE:KNE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage37.21%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)C$529.80KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)C$260K Get KNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Kane Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KNE Insider Buying and Selling by Quarter Kane Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/17/2025Marc EdwardsDirectorBuy2,000,000C$0.10C$200,000.009/13/2024Robert HuizingaDirectorBuy90,000C$0.13C$11,250.007/29/2024Marc EdwardsDirectorBuy150,000C$0.14C$20,250.006/25/2024Marc EdwardsDirectorBuy345,000C$0.14C$48,300.004/17/2024Philip RenaudDirectorSell2,000,000C$0.13C$260,000.009/11/2023Richard J. RenaudInsiderBuy3,125,000C$0.08C$250,000.00 (Data available from 1/1/2013 forward) KNE Insider Trading Activity - Frequently Asked Questions Who is on Kane Biotech's Insider Roster? The list of insiders at Kane Biotech includes Marc Edwards, Philip Renaud, Richard J. Renaud, and Robert Huizinga. Learn more on insiders at KNE. What percentage of Kane Biotech stock is owned by insiders? 37.21% of Kane Biotech stock is owned by insiders. Learn more on KNE's insider holdings. Which Kane Biotech insiders have been buying company stock? The following insiders have purchased KNE shares in the last 24 months: Marc Edwards (C$268,550.00), and Robert Huizinga (C$11,250.00). How much insider buying is happening at Kane Biotech? Insiders have purchased a total of 2,585,000 KNE shares in the last 24 months for a total of C$279,800.00 bought. More Insider Trading Tools from MarketBeat Related Companies Hemostemix Insider Trades Innovotech Insider Trades Quest PharmaTech Insider Trades Oncolytics Biotech Insider Trades Fennec Pharmaceuticals Insider Trades Theratechnologies Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (CVE:KNE) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kane Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
